Smoking cessation quickly reduces mortality, within 3 years

It’s been long-established that quitting smoking prolongs life and that quitting young (below about 40) eliminates all or almost all the mortality costs of smoking. The new paper Smoking Cessation and Short- and Longer-Term Mortality by Eo Rin Cho and colleagues extends this case to more recent data and from several countries. While they confirmContinue reading “Smoking cessation quickly reduces mortality, within 3 years”

British smokers understand risks of e-cig use better than a lot of British health officials and scientists

England remains the country in which the government and (most of the) health establishment continue to aggressively promote e-cigarettes as a better alternative to cigarettes. As a result, Sarah Jackson and her colleagues were concerned about the results of their latest survey of smokers’ attitudes towards e-cigarettes, reported in their paper Trends in Harm PerceptionsContinue reading “British smokers understand risks of e-cig use better than a lot of British health officials and scientists”

More information on how ecigs increase cardiovascular disease risk

The evidence that e-cigarette use is associated with increased cardiovascular disease keeps accumulaing, together with studies on the specific pathophysiological mechanisms through which e-cigarette use increases disease risk. The recent review by Huiqi Zong, Zhekai Hu and colleagues, Electronic cigarettes and cardiovascular disease: epidemiological and biological links, is the most recent summary of this evidence.Continue reading “More information on how ecigs increase cardiovascular disease risk”

E-cigs have similar risks to cigs for some diseases and nearly as high for others. Dual use riskier than smoking alone

It is an article of faith among e-cigarette advocates that they are substantially less risky than cigarettes. Rather than being based on the actual associations between e-cigarette use and disease, this belief is based on the fact that e-cigarettes do not burn tobacco, so avoid the toxic combustion products that cigarettes produce. In recent years,Continue reading “E-cigs have similar risks to cigs for some diseases and nearly as high for others. Dual use riskier than smoking alone”

Banning menthol leads a quarter of menthol smokers to quit

The two justifications for the FDA’s proposed product standard prohibiting menthol cigarettes and cigars are (1) it will reduce youth initiation, and (2) it will help menthol smokers to quit. Now Sarah Mills and colleagues have published a review and meta-analysis of the effects of menthol bans around the world, The Impact of Menthol CigaretteContinue reading “Banning menthol leads a quarter of menthol smokers to quit”

Relevant to COP10: Pharmaceuticalisation as the tobacco industry’s endgame

Yogi Hendlin, Eileen Han and Pam Ling’s new paper Pharmaceuticalisation as the tobacco industry’s endgame provides a detailed analysis of how the multinational tobacco companies have developed and used the companies efforts to reposition themselves a source for “clean” nicotine while simultaneously maintaining and expanding their sales of cigarettes and other “traditional” tobacco products whereContinue reading “Relevant to COP10: Pharmaceuticalisation as the tobacco industry’s endgame”

Replacing 50% of cigs with ecigs or HTP had no lung benefit

E-cigarette advocates and tobacco harm reduction advocates, as well as the FDA, have long promoted a 50% reduction in cigarette smoking as a positive outcome when assessing the value of e-cigarettes (recent example). The FDA’s use of this benchmark is particularly surprising because in 2021 FDA scientists published a meta-analysis of the effects of smokers reducingContinue reading “Replacing 50% of cigs with ecigs or HTP had no lung benefit”

Cochrane Collaborative concludes that e-cigs as medicines help a few people shop smoking (again); still ignoring differences between medicines and consumer products as well as dual use

On January 8, 2024, the Cochrane Collaborative published yet another meta-analysis of randomized controlled trials concluding that e-cigarettes help a few people stop smoking. While industry and other pro-e-cigarette interests will make a big deal of this, the fact is that there is nothing new here. Here is their primary conclusion: There is high certaintyContinue reading “Cochrane Collaborative concludes that e-cigs as medicines help a few people shop smoking (again); still ignoring differences between medicines and consumer products as well as dual use”

E-cigarettes associated with heart attacks in never smokers

Since we published the first study demonstrating that e-cigarette use was associated with higher odds of having had a heart attack, e-cigarette advocates have argued that this association was an artifact of current or former cigarette smoking or “reverse causation” due to smokers starting to use e-cigarettes after they had a heart attack.  Now TalalContinue reading “E-cigarettes associated with heart attacks in never smokers”

Youth living in vapefree homes much less likely to use e-cigs

While the reason for enacting smokefree laws and implementing voluntary smokefree policies has been to protect people from secondhand smoke, a well-established side effect is that they help adult smokers quit and help prevent youth smoking (laws, home policies). Now Jeremy Staff and his colleagues have shown that kids living in vapefree households are muchContinue reading “Youth living in vapefree homes much less likely to use e-cigs”